214 related articles for article (PubMed ID: 21656910)
1. A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer.
Remily-Wood ER; Liu RZ; Xiang Y; Chen Y; Thomas CE; Rajyaguru N; Kaufman LM; Ochoa JE; Hazlehurst L; Pinilla-Ibarz J; Lancet J; Zhang G; Haura E; Shibata D; Yeatman T; Smalley KS; Dalton WS; Huang E; Scott E; Bloom GC; Eschrich SA; Koomen JM
Proteomics Clin Appl; 2011 Aug; 5(7-8):383-96. PubMed ID: 21656910
[TBL] [Abstract][Full Text] [Related]
2. Determination of the heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin in plasma by liquid chromatography-electrospray mass spectrometry.
Hwang K; Scripture CD; Gutierrez M; Kummar S; Figg WD; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):35-40. PubMed ID: 16260191
[TBL] [Abstract][Full Text] [Related]
3. Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.
Abbatiello SE; Schilling B; Mani DR; Zimmerman LJ; Hall SC; MacLean B; Albertolle M; Allen S; Burgess M; Cusack MP; Gosh M; Hedrick V; Held JM; Inerowicz HD; Jackson A; Keshishian H; Kinsinger CR; Lyssand J; Makowski L; Mesri M; Rodriguez H; Rudnick P; Sadowski P; Sedransk N; Shaddox K; Skates SJ; Kuhn E; Smith D; Whiteaker JR; Whitwell C; Zhang S; Borchers CH; Fisher SJ; Gibson BW; Liebler DC; MacCoss MJ; Neubert TA; Paulovich AG; Regnier FE; Tempst P; Carr SA
Mol Cell Proteomics; 2015 Sep; 14(9):2357-74. PubMed ID: 25693799
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
5. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
Karkoulis PK; Stravopodis DJ; Voutsinas GE
Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
[TBL] [Abstract][Full Text] [Related]
6. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.
Zhang H; Liu Q; Zimmerman LJ; Ham AJ; Slebos RJ; Rahman J; Kikuchi T; Massion PP; Carbone DP; Billheimer D; Liebler DC
Mol Cell Proteomics; 2011 Jun; 10(6):M110.006593. PubMed ID: 21357624
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics reveals that Hsp90 inhibition preferentially targets kinases and the DNA damage response.
Sharma K; Vabulas RM; Macek B; Pinkert S; Cox J; Mann M; Hartl FU
Mol Cell Proteomics; 2012 Mar; 11(3):M111.014654. PubMed ID: 22167270
[TBL] [Abstract][Full Text] [Related]
8. Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins.
Chen Y; Fisher KJ; Lloyd M; Wood ER; Coppola D; Siegel E; Shibata D; Chen YA; Koomen JM
Methods Mol Biol; 2017; 1647():19-45. PubMed ID: 28808993
[TBL] [Abstract][Full Text] [Related]
9. Systematic identification of the HSP90 candidate regulated proteome.
Wu Z; Gholami AM; Kuster B
Mol Cell Proteomics; 2012 Jun; 11(6):M111.016675. PubMed ID: 22337586
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.
Song D; Chaerkady R; Tan AC; García-García E; Nalli A; Suárez-Gauthier A; López-Ríos F; Zhang XF; Solomon A; Tong J; Read M; Fritz C; Jimeno A; Pandey A; Hidalgo M
Mol Cancer Ther; 2008 Oct; 7(10):3275-84. PubMed ID: 18852131
[TBL] [Abstract][Full Text] [Related]
11. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
Lang SA; Klein D; Moser C; Gaumann A; Glockzin G; Dahlke MH; Dietmaier W; Bolder U; Schlitt HJ; Geissler EK; Stoeltzing O
Mol Cancer Ther; 2007 Mar; 6(3):1123-32. PubMed ID: 17363505
[TBL] [Abstract][Full Text] [Related]
13. The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor.
Kobayashi N; Toyooka S; Soh J; Yamamoto H; Dote H; Kawasaki K; Otani H; Kubo T; Jida M; Ueno T; Ando M; Ogino A; Kiura K; Miyoshi S
Lung Cancer; 2012 Feb; 75(2):161-6. PubMed ID: 21767894
[TBL] [Abstract][Full Text] [Related]
14. Multi-functional MBIT for peptide tandem mass spectrometry.
Yoon HJ; Seo J; Shin SK
Mass Spectrom Rev; 2015; 34(2):209-18. PubMed ID: 24872020
[TBL] [Abstract][Full Text] [Related]
15. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.
Sydor JR; Normant E; Pien CS; Porter JR; Ge J; Grenier L; Pak RH; Ali JA; Dembski MS; Hudak J; Patterson J; Penders C; Pink M; Read MA; Sang J; Woodward C; Zhang Y; Grayzel DS; Wright J; Barrett JA; Palombella VJ; Adams J; Tong JK
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17408-13. PubMed ID: 17090671
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
Khaledian B; Taguchi A; Shin-Ya K; Kondo-Ida L; Kagaya N; Suzuki M; Kajino T; Yamaguchi T; Shimada Y; Takahashi T
Cancer Sci; 2021 Mar; 112(3):1225-1234. PubMed ID: 33370472
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed Immunoaffinity Enrichment of Peptides with Anti-peptide Antibodies and Quantification by Stable Isotope Dilution Multiple Reaction Monitoring Mass Spectrometry.
Kuhn E; Carr SA
Methods Mol Biol; 2016; 1410():135-67. PubMed ID: 26867743
[TBL] [Abstract][Full Text] [Related]
19. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
20. Impact of Heat Shock Protein 90 Inhibition on the Proteomic Profile of Lung Adenocarcinoma as Measured by Two-Dimensional Electrophoresis Coupled with Mass Spectrometry.
Marrugal Á; Ferrer I; Pastor MD; Ojeda L; Quintanal-Villalonga Á; Carnero A; Molina-Pinelo S; Paz-Ares L
Cells; 2019 Jul; 8(8):. PubMed ID: 31370342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
